NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
NeoImmuneTech
NeoImmuneTech
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Hoffmann-La Roche
Weill Medical College of Cornell University
Revolution Medicines, Inc.
H. Lee Moffitt Cancer Center and Research Institute
University of Washington